866-997-4948(US-Canada Toll Free)

United States Immunotherapy Drugs Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 100 Pages

In this report, the United States Immunotherapy Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Immunotherapy Drugs in these regions, from 2012 to 2022 (forecast).

United States Immunotherapy Drugs market competition by top manufacturers/players, with Immunotherapy Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
ELI Lilly and Company
Merck & Co., Inc
F. Hoffmann-La Roche AG
Novartis International AG
Johnson & Johnson
Glaxosmithkline PLC
Amgen Inc.
Abbvie
Astrazeneca
Bristol-Myers Squibb

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Immunotherapy Drugs for each application, including
Cancer
Autoimmune Diseases
Infectious Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.
 

Table of Contents

United States Immunotherapy Drugs Market Report 2017
1 Immunotherapy Drugs Overview
1.1 Product Overview and Scope of Immunotherapy Drugs
1.2 Classification of Immunotherapy Drugs by Product Category
1.2.1 United States Immunotherapy Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Immunotherapy Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Adult Vaccines
1.2.4 Checkpoint Inhibitors
1.2.5 Interferons Alpha
1.3 United States Immunotherapy Drugs Market by Application/End Users
1.3.1 United States Immunotherapy Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infectious Diseases
1.4 United States Immunotherapy Drugs Market by Region
1.4.1 United States Immunotherapy Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Immunotherapy Drugs Status and Prospect (2012-2022)
1.4.3 Southwest Immunotherapy Drugs Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Immunotherapy Drugs Status and Prospect (2012-2022)
1.4.5 New England Immunotherapy Drugs Status and Prospect (2012-2022)
1.4.6 The South Immunotherapy Drugs Status and Prospect (2012-2022)
1.4.7 The Midwest Immunotherapy Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Immunotherapy Drugs (2012-2022)
1.5.1 United States Immunotherapy Drugs Sales and Growth Rate (2012-2022)
1.5.2 United States Immunotherapy Drugs Revenue and Growth Rate (2012-2022)

2 United States Immunotherapy Drugs Market Competition by Players/Suppliers
2.1 United States Immunotherapy Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Immunotherapy Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Immunotherapy Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Immunotherapy Drugs Market Competitive Situation and Trends
2.4.1 United States Immunotherapy Drugs Market Concentration Rate
2.4.2 United States Immunotherapy Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Immunotherapy Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Immunotherapy Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Immunotherapy Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Immunotherapy Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Immunotherapy Drugs Price by Region (2012-2017)

4 United States Immunotherapy Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Immunotherapy Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Immunotherapy Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Immunotherapy Drugs Price by Type (2012-2017)
4.4 United States Immunotherapy Drugs Sales Growth Rate by Type (2012-2017)

5 United States Immunotherapy Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Immunotherapy Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Immunotherapy Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Immunotherapy Drugs Players/Suppliers Profiles and Sales Data
6.1 ELI Lilly and Company
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Immunotherapy Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 ELI Lilly and Company Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck & Co., Inc
6.2.2 Immunotherapy Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck & Co., Inc Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 F. Hoffmann-La Roche AG
6.3.2 Immunotherapy Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 F. Hoffmann-La Roche AG Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Novartis International AG
6.4.2 Immunotherapy Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novartis International AG Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson
6.5.2 Immunotherapy Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Johnson & Johnson Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Glaxosmithkline PLC
6.6.2 Immunotherapy Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Glaxosmithkline PLC Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Amgen Inc.
6.7.2 Immunotherapy Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Amgen Inc. Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Abbvie
6.8.2 Immunotherapy Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Abbvie Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Astrazeneca
6.9.2 Immunotherapy Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Astrazeneca Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Bristol-Myers Squibb
6.10.2 Immunotherapy Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Bristol-Myers Squibb Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Immunotherapy Drugs Manufacturing Cost Analysis
7.1 Immunotherapy Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immunotherapy Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Immunotherapy Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immunotherapy Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Immunotherapy Drugs Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Immunotherapy Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Immunotherapy Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Immunotherapy Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Immunotherapy Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

 

List of Table

List of Tables and Figures

Figure Product Picture of Immunotherapy Drugs
Figure United States Immunotherapy Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Immunotherapy Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Adult Vaccines Product Picture
Figure Checkpoint Inhibitors Product Picture
Figure Interferons Alpha Product Picture
Figure United States Immunotherapy Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Immunotherapy Drugs by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Autoimmune Diseases Examples
Table Key Downstream Customer in Autoimmune Diseases
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure United States Immunotherapy Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Immunotherapy Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Immunotherapy Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Immunotherapy Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Immunotherapy Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Immunotherapy Drugs Sales Share by Players/Suppliers
Figure 2017 United States Immunotherapy Drugs Sales Share by Players/Suppliers
Figure United States Immunotherapy Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Immunotherapy Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Immunotherapy Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Immunotherapy Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Immunotherapy Drugs Revenue Share by Players/Suppliers
Table United States Market Immunotherapy Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Immunotherapy Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Immunotherapy Drugs Market Share of Top 3 Players/Suppliers
Figure United States Immunotherapy Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Immunotherapy Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Immunotherapy Drugs Product Category
Table United States Immunotherapy Drugs Sales (K Units) by Region (2012-2017)
Table United States Immunotherapy Drugs Sales Share by Region (2012-2017)
Figure United States Immunotherapy Drugs Sales Share by Region (2012-2017)
Figure United States Immunotherapy Drugs Sales Market Share by Region in 2016
Table United States Immunotherapy Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Immunotherapy Drugs Revenue Share by Region (2012-2017)
Figure United States Immunotherapy Drugs Revenue Market Share by Region (2012-2017)
Figure United States Immunotherapy Drugs Revenue Market Share by Region in 2016
Table United States Immunotherapy Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Immunotherapy Drugs Sales (K Units) by Type (2012-2017)
Table United States Immunotherapy Drugs Sales Share by Type (2012-2017)
Figure United States Immunotherapy Drugs Sales Share by Type (2012-2017)
Figure United States Immunotherapy Drugs Sales Market Share by Type in 2016
Table United States Immunotherapy Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Immunotherapy Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Immunotherapy Drugs by Type (2012-2017)
Figure Revenue Market Share of Immunotherapy Drugs by Type in 2016
Table United States Immunotherapy Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Immunotherapy Drugs Sales Growth Rate by Type (2012-2017)
Table United States Immunotherapy Drugs Sales (K Units) by Application (2012-2017)
Table United States Immunotherapy Drugs Sales Market Share by Application (2012-2017)
Figure United States Immunotherapy Drugs Sales Market Share by Application (2012-2017)
Figure United States Immunotherapy Drugs Sales Market Share by Application in 2016
Table United States Immunotherapy Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Immunotherapy Drugs Sales Growth Rate by Application (2012-2017)
Table ELI Lilly and Company Basic Information List
Table ELI Lilly and Company Immunotherapy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ELI Lilly and Company Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure ELI Lilly and Company Immunotherapy Drugs Sales Market Share in United States (2012-2017)
Figure ELI Lilly and Company Immunotherapy Drugs Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc Basic Information List
Table Merck & Co., Inc Immunotherapy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc Immunotherapy Drugs Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc Immunotherapy Drugs Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Immunotherapy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Immunotherapy Drugs Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche AG Immunotherapy Drugs Revenue Market Share in United States (2012-2017)
Table Novartis International AG Basic Information List
Table Novartis International AG Immunotherapy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis International AG Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Novartis International AG Immunotherapy Drugs Sales Market Share in United States (2012-2017)
Figure Novartis International AG Immunotherapy Drugs Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Immunotherapy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Immunotherapy Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Immunotherapy Drugs Revenue Market Share in United States (2012-2017)
Table Glaxosmithkline PLC Basic Information List
Table Glaxosmithkline PLC Immunotherapy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Glaxosmithkline PLC Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Glaxosmithkline PLC Immunotherapy Drugs Sales Market Share in United States (2012-2017)
Figure Glaxosmithkline PLC Immunotherapy Drugs Revenue Market Share in United States (2012-2017)
Table Amgen Inc. Basic Information List
Table Amgen Inc. Immunotherapy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Inc. Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Amgen Inc. Immunotherapy Drugs Sales Market Share in United States (2012-2017)
Figure Amgen Inc. Immunotherapy Drugs Revenue Market Share in United States (2012-2017)
Table Abbvie Basic Information List
Table Abbvie Immunotherapy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbvie Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Abbvie Immunotherapy Drugs Sales Market Share in United States (2012-2017)
Figure Abbvie Immunotherapy Drugs Revenue Market Share in United States (2012-2017)
Table Astrazeneca Basic Information List
Table Astrazeneca Immunotherapy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astrazeneca Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Astrazeneca Immunotherapy Drugs Sales Market Share in United States (2012-2017)
Figure Astrazeneca Immunotherapy Drugs Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Immunotherapy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Immunotherapy Drugs Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Immunotherapy Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immunotherapy Drugs
Figure Manufacturing Process Analysis of Immunotherapy Drugs
Figure Immunotherapy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Immunotherapy Drugs Major Players/Suppliers in 2016
Table Major Buyers of Immunotherapy Drugs
Table Distributors/Traders List
Figure United States Immunotherapy Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Immunotherapy Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Immunotherapy Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Immunotherapy Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Immunotherapy Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Immunotherapy Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Immunotherapy Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Immunotherapy Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Immunotherapy Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Immunotherapy Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Immunotherapy Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Immunotherapy Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *